Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 399-402

  Takai, Noriyuki ^a   Kira, Naoko ^a   Ishii, Terukazu ^a   Yoshida, Toshie ^a   Nishida, Masakazu ^a   Nishida, Yoshihiro ^a   Nasu, Kaei ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bufalin; Cancer; Cell cycle; Traditional oriental medicines

Indexed keywords

ANTINEOPLASTIC AGENT; BUFADIENOLIDE DERIVATIVE; BUFALIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG SCREENING; HUMAN; NEOPLASM; ORIENTAL MEDICINE; PATHOLOGY; PHYTOTHERAPY; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BUFANOLIDES; CELL CYCLE; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; MEDICINE, EAST ASIAN TRADITIONAL; NEOPLASMS; PHYTOTHERAPY; TUMOR CELLS, CULTURED;

EID: 84864886686     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.399     Document Type: Note

References (23)

1. Chueh FS, Chen YY, Huang AC, et al (2011). Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol, in press.
2. Dong Y, Yin S, Li J, et al (2011). Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis, 16, 394-403.
3. Han KQ, Huang G, Gu W, et al (2007). Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol, 13, 3374-9.
4. Hong SH, Choi YH (2012). Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells. Oncol Rep, 27, 114-20.
5. Hong Z, Chen K, Yeung HW (1992). Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu Shen Wan, by liquid chromatography. J Pharm Pharmacol, 44, 1023-6.
6. Jiang Y, Zhang Y, Luan J, et al (2010). Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology, 62, 573-83.
7. Jing Y, Watabe M, Hashimoto S, et al (1994a). Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res, 14, 1193-8.
8. Jing Y, Ohizumi H, Kawazoe N, et al (1994b). Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res, 85, 645-51.
9. Kawazoe N, Watabe M, Masuda Y, et al (1999). Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene, 18, 2413-21.
10. Krenn L, Kopp B (1998). Bufadienolides from animal and plant sources. Phytochemistry, 48, 1-29.
11. Li D, Qu X, Hou K, et al (2009). PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs, 20, 59-64.
12. Masuda Y, Kawazoe N, Nakajo S, et al (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res, 19, 549-56.
13. Meng Z, Yang P, Shen Y, et al (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer, 115, 5309-18.
14. Morishita S, Shoji M, Oguni Y (1992). Pharmacological actions of 'Kyusin', a drug containing toad venom: cardiotonic and arrhythmogenic effects. Am J Chin Med, 20, 245-6.
15. Numazawa S, Shinoki M, Ito H, et al (1994). Involvement of Na+,K+-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol, 160, 113-20.
16. Panesar NS (1992). Bufalin and unidentified substance(s) in traditional Chinese medicine cross-react in commercial digoxin assay. Clin Chem, 38, 2155-6.
17. Song H, Guo T, Bi K, et al (2000). Determination of resibufogenin and cinobufagin in heart-protecting musk pill by HPLC. Biomed Chromatogr, 14, 130-2.
18. Takai N, Ueda T, Nishida M, et al (2008). Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med, 21, 637-43.
19. Watabe M, Ito K, Masuda Y, et al. (1998). Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene, 16, 779-87.
20. Xie CM, Chan WY, Yu S, et al (2011). Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radical Biol Med, 51, 1365-75.
21. Yeh J-Y, Huang WJ, Kan S-F, et al (2003). Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate, 54, 112-24.
22. Yu CH, Kan SF, Pu HF, et al (2008). Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci, 99, 2467-76.
23. Zhang LS, Nakaya K, Yoshida T, et al (1991). Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun, 178, 686-93.